Disaggregating the liability for drug abuse.

نویسندگان

  • R E Tarter
  • H Moss
  • T Blackson
  • M Vanyukov
  • J Brigham
  • R Loeber
چکیده

It is consensually accepted that the liability for developing a substance abuse disorder is not the same for all individuals in the population. Only marginal progress has been made, however, in determining the factors responsible for the variation in the liability to drug abuse, encompassing interacting biological, behavioral, and environmental processes. Since variation in the liability has a multifactorial basis, it is necessary, therefore, to identify the integral biobehavioral traits and to determine how a person’s position on these traits (phenotypes) covaries with environmental influences to determine liability status. Once this can be accomplished, it will be possible to specify with a high level of precision the liability for developing a drug abuse disorder for each individual in the population.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Relative abuse liability of triazolam: experimental assessment in animals and humans.

The abuse liability of a drug is a positive, interactive function of the reinforcing and adverse effects of the drug. The relative abuse liability of the hypnotic benzodiazepine, triazolam, has been controversial. This paper reviews animal and human studies bearing on its relative abuse liability, including data on pharmacological profile, reinforcing effects, liking, speed of onset, discrimina...

متن کامل

Incorporating the assessment of abuse liability into the drug discovery and development process.

Evaluation of abuse liability is one of many obligations incurred by industrial sponsors in the development of medications acting on substrates in the central nervous system. In addition to providing the information necessary for a scheduling recommendation in the marketing application, the abuse liability assessment allows sponsors to estimate safety and commercial risks associated with schedu...

متن کامل

Prediction and Prevention of Prescription Drug Abuse: Role of Preclinical Assessment of Substance Abuse Liability.

In 2011, the prevalence of prescription drug abuse exceeded that of any other illicit drug except marijuana. Consequently, efforts to curtail abuse of new medications should begin during the drug development process, where abuse liability can be identified and addressed before a candidate medication has widespread use. The first step in this process is scheduling with the Drug Enforcement Agenc...

متن کامل

Risk identification, risk assessment, and risk management of abusable drug formulations.

There is a demand for pharmaceutical products with reduced abuse liability. These products must meet three tests to be successful. They must be safe for patients, be less likely to injure the abuser, and be less desirable for abuse by established drug abusers relative to existing products on a dose for dose (milligram-equivalent) basis. There is a need for standardization of the evaluation of a...

متن کامل

بررسی اپیدمیولوژی مرگ و میر ناشی از سوء مصرف مواد مخدر در اجساد ارجاعی به اداره کل پزشکی قانونی استان مازندران

Background and purpose: Substance abuse is one of the most important problems which leave a high level of burden in the areas of medical and social care, economic and culture in a society. Global epidemic of drug abuse and the resulting liability are increasing in all countries, especially in developing countries. This is considered amongst the main reasons for premature death. General manag...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • NIDA research monograph

دوره 169  شماره 

صفحات  -

تاریخ انتشار 1998